Celltrion Pharm Market Cap

Celltrion Pharm has a market cap or net worth of 2.56 trillion as of April 28, 2026. Its market cap has increased by 20.60% in one year.

Market Cap

2.56T

Enterprise Value

n/a

Revenue

274.73B

Ranking

n/a

PE Ratio

99.25

Stock Price

57,900.00

Market Cap Chart

Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.56T, an increase of 3,757.11%. That is a compound annual growth rate of 19.77%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	2,560.02B	-0.52%
Dec 30, 2025	2,573.33B	4.33%
Dec 30, 2024	2,466.43B	-35.41%
Dec 28, 2023	3,818.49B	44.48%
Dec 29, 2022	2,642.93B	-43.45%
Dec 30, 2021	4,673.68B	-46.31%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hanall Biopharma	2,620.29B
Daewoong Pharmaceutical	1,753.56B
GC Biopharma	1,630.94B
Chong Kun Dang Pharmaceutical	1,175.31B
DongKook Pharmaceutical	1,168.37B
Hanmi Pharm.	6,308.41B
Yuhan	7,041.38B
Daewoong	942.53B

Market Cap Rankings